| Reference |
|---|
Ravid Lustig L, Sampath Kumar A, Schw xe4 mmle T, Dunkel I, Noviello G, Limberg E, et al. GATA transcription factors drive initial Xist upregulation after fertilization through direct activation of long-range enhancers. Nat Cell Biol. 2023;25:1704-1715 pubmed publisher |
Li Y, Tan M, Sun S, Stea E, Pang B. Targeted CRISPR activation and knockout screenings identify novel doxorubicin transporters. Cell Oncol (Dordr). 2023;: pubmed publisher |
Shamloo S, Kloetgen A, Petroulia S, Hockemeyer K, Sievers S, Tsirigos A, et al. Integrative CRISPR Activation and Small Molecule Inhibitor Screening for lncRNA Mediating BRAF Inhibitor Resistance in Melanoma. Biomedicines. 2023;11: pubmed publisher |
Couto J, Vulin M, Jehanno C, Coissieux M, Hamelin B, Schmidt A, et al. Nicotinamide N-methyltransferase sustains a core epigenetic program that promotes metastatic colonization in breast cancer. EMBO J. 2023;42:e112559 pubmed publisher |
Gil N, Perry R, Mukamel Z, Tuck A, B xfc hler M, Ulitsky I. Complex regulation of Eomes levels mediated through distinct functional features of the Meteor long non-coding RNA locus. Cell Rep. 2023;42:112569 pubmed publisher |
Shi J, Xin H, Shao Y, Dai S, Tan N, Li Z, et al. CRISPR-Based KCC2 Upregulation Attenuates Drug-Resistant Seizure in Mouse Models of Epilepsy. Ann Neurol. 2023;94:91-105 pubmed publisher |
King C, Liu Y, Amato K, Schaack G, Hu T, Smith J, et al. Pathogen-driven CRISPR screens identify TREX1 as a regulator of DNA self-sensing during influenza virus infection. bioRxiv. 2023;: pubmed publisher |
Jin Q, Liu X, Zhuang Z, Huang J, Gou S, Shi H, et al. Doxycycline-dependent Cas9-expressing pig resources for conditional in vivo gene nullification and activation. Genome Biol. 2023;24:8 pubmed publisher |
Wang N, He J, Feng X, Liao S, Zhao Y, Tang F, et al. Single-cell profiling of lncRNAs in human germ cells and molecular analysis reveals transcriptional regulation of LNC1845 on LHX8. elife. 2023;12: pubmed publisher |
Zhang X, Luo Y, Cen Y, Qiu X, Li J, Jie M, et al. MACC1 promotes pancreatic cancer metastasis by interacting with the EMT regulator SNAI1. Cell Death Dis. 2022;13:923 pubmed publisher |
Paris A, Tardif N, Baietti F, Berra C, Leclair H, Leucci E, et al. The AhR-SRC axis as a therapeutic vulnerability in BRAFi-resistant melanoma. EMBO Mol Med. 2022;14:e15677 pubmed publisher |
Zhang X, Jiang Q, Li J, Zhang S, Cao Y, Xia X, et al. KCNQ1OT1 promotes genome-wide transposon repression by guiding RNA-DNA triplexes and HP1 binding. Nat Cell Biol. 2022;24:1617-1629 pubmed publisher |
Hou G, Zhou T, Xu N, Yin Z, Zhu X, Zhang Y, et al. Integrative functional genomics identifies SLE causal genetic variant in the IRF5 risk locus. Arthritis Rheumatol. 2022;: pubmed publisher |
Beucher A, Miguel Escalada I, Balboa D, De Vas M, Maestro M, García Hurtado J, et al. The HASTER lncRNA promoter is a cis-acting transcriptional stabilizer of HNF1A. Nat Cell Biol. 2022;24:1528-1540 pubmed publisher |
Khatib J, Schleicher E, Jackson L, Dhoonmoon A, Moldovan G, Nicolae C. Complementary CRISPR genome-wide genetic screens in PARP10-knockout and overexpressing cells identify synthetic interactions for PARP10-mediated cellular survival. Oncotarget. 2022;13:1078-1091 pubmed publisher |
Voloudakis G, Vicari J, Venkatesh S, Hoffman G, Dobrindt K, Zhang W, et al. A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility. NPJ Genom Med. 2022;7:52 pubmed publisher |
Shevchenko A, Rifel N, Zakian S, Zakharova I. Constitutive heterochromatin propagation contributes to the X chromosome inactivation. Chromosome Res. 2022;30:289-307 pubmed publisher |
Fu H, Wang T, Kong X, Yan K, Yang Y, Cao J, et al. A Nodal enhanced micropeptide NEMEP regulates glucose uptake during mesendoderm differentiation of embryonic stem cells. Nat Commun. 2022;13:3984 pubmed publisher |
Yu C, Lei X, Chen F, Mao S, Lv L, Liu H, et al. ARID1A loss derepresses a group of human endogenous retrovirus-H loci to modulate BRD4-dependent transcription. Nat Commun. 2022;13:3501 pubmed publisher |
Zhang Q, Wang S, Li W, Yau E, Hui H, Singh P, et al. Genome-wide CRISPR/Cas9 transcriptional activation screen identifies a histone acetyltransferase inhibitor complex as a regulator of HIV-1 integration. Nucleic Acids Res. 2022;: pubmed publisher |
Huang M, Yang F, Zhang D, Lin M, Duan H, El Mayta R, et al. Endothelial plasticity drives aberrant vascularization and impedes cardiac repair after myocardial infarction. Nat Cardiovasc Res. 2022;1:372-388 pubmed publisher |
Feser C, Lees C, Lammers D, Riddle M, Bingham J, Eckert M, et al. Engineering CRISPR/Cas9 for Multiplexed Recombinant Coagulation Factor Production. Int J Mol Sci. 2022;23: pubmed publisher |
Zhou T, Zhu X, Ye Z, Wang Y, Yao C, Xu N, et al. Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery. Nat Commun. 2022;13:1855 pubmed publisher |
Giehrl Schwab J, Giesert F, Rauser B, Lao C, Hembach S, Lefort S, et al. Parkinson's disease motor symptoms rescue by CRISPRa-reprogramming astrocytes into GABAergic neurons. EMBO Mol Med. 2022;14:e14797 pubmed publisher |
Joung J, Kirchgatterer P, Singh A, Cho J, Nety S, Larson R, et al. CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity. Nat Commun. 2022;13:1606 pubmed publisher |
Sofer S, Lamkiewicz K, Armoza Eilat S, Partouche S, Marz M, Moskovits N, et al. A genome-wide CRISPR activation screen reveals Hexokinase 1 as a critical factor in promoting resistance to multi-kinase inhibitors in hepatocellular carcinoma cells. FASEB J. 2022;36:e22191 pubmed publisher |
Hirakawa M, Tjahjono N, Light Y, Celebi A, Celebi N, Chintalapudi P, et al. Upregulation of CD14 in mesenchymal stromal cells accelerates lipopolysaccharide-induced response and enhances antibacterial properties. iScience. 2022;25:103759 pubmed publisher |
Grinkevitch V, Wappett M, Crawford N, Price S, Lees A, McCann C, et al. Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists. Mol Cancer Ther. 2022;21:594-606 pubmed publisher |
Jiang L, Liang J, Huang W, Ma J, Park K, Wu Z, et al. CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy. Mol Ther. 2022;30:54-74 pubmed publisher |
Ikeuchi W, Wakita Y, Zhang G, Li C, Itakura K, Yamakawa T. AT-rich interaction domain 5A regulates the transcription of interleukin-6 gene in prostate cancer cells. Prostate. 2022;82:97-106 pubmed publisher |
Dhungel B, Monteuuis G, Giardina C, Tabar M, Feng Y, Metierre C, et al. The Fusion of CLEC12A and MIR223HG Arises from a trans-Splicing Event in Normal and Transformed Human Cells. Int J Mol Sci. 2021;22: pubmed publisher |
Peng W, Koirala P, Zhou H, Jiang J, Zhang Z, Yang L, et al. Lnc-DC promotes estrogen independent growth and tamoxifen resistance in breast cancer. Cell Death Dis. 2021;12:1000 pubmed publisher |
Zhu S, Liu Y, Zhou Z, Zhang Z, Xiao X, Liu Z, et al. Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry. Sci China Life Sci. 2021;: pubmed publisher |
Perez García V, Lea G, Lopez Jimenez P, Okkenhaug H, Burton G, Moffett A, et al. BAP1/ASXL complex modulation regulates epithelial-mesenchymal transition during trophoblast differentiation and invasion. elife. 2021;10: pubmed publisher |
Ramaker R, Hardigan A, Gordon E, Wright C, Myers R, Cooper S. Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition. BMC Cancer. 2021;21:632 pubmed publisher |
Alda Catalinas C, Eckersley Maslin M, Reik W. Pooled CRISPR-activation screening coupled with single-cell RNA-seq in mouse embryonic stem cells. STAR Protoc. 2021;2:100426 pubmed publisher |
Tian C, Huang Y, Clauser K, Rickelt S, Lau A, Carr S, et al. Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells. Nat Commun. 2021;12:2328 pubmed publisher |
Zilli F, Marques Ramos P, Auf der Maur P, Jehanno C, Sethi A, Coissieux M, et al. The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells. EMBO Mol Med. 2021;13:e13162 pubmed publisher |
Hou G, Harley I, Lu X, Zhou T, Xu N, Yao C, et al. SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression. Nat Commun. 2021;12:135 pubmed publisher |
Clements K, Schleicher E, Thakar T, Hale A, Dhoonmoon A, Tolman N, et al. Identification of regulators of poly-ADP-ribose polymerase inhibitor response through complementary CRISPR knockout and activation screens. Nat Commun. 2020;11:6118 pubmed publisher |
Schleicher E, Dhoonmoon A, Jackson L, Clements K, Stump C, Nicolae C, et al. Dual genome-wide CRISPR knockout and CRISPR activation screens identify mechanisms that regulate the resistance to multiple ATR inhibitors. PLoS Genet. 2020;16:e1009176 pubmed publisher |
Shin H, Kweon J, Kim Y. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a. Methods Mol Biol. 2021;2162:185-193 pubmed publisher |
Chen C, Enomoto A, Weng L, Taki T, Shiraki Y, Mii S, et al. Complex roles of the actin-binding protein Girdin/GIV in DNA damage-induced apoptosis of cancer cells. Cancer Sci. 2020;111:4303-4317 pubmed publisher |
Alda Catalinas C, Bredikhin D, Hernando Herraez I, Santos F, Kubinyecz O, Eckersley Maslin M, et al. A Single-Cell Transcriptomics CRISPR-Activation Screen Identifies Epigenetic Regulators of the Zygotic Genome Activation Program. Cell Syst. 2020;11:25-41.e9 pubmed publisher |
Kirchner S, Reuter S, Westphal A, Mrowka R. Decipher the complexity of cis-regulatory regions by a modified Cas9. PLoS ONE. 2020;15:e0235530 pubmed publisher |
Liao Z, Lee J, Krakowiak J, Wang R, Li W. Enforced Activation of Enhancer RNAs In Situ through the dCas9 Synergistic Activation Mediator System. J Vis Exp. 2020;: pubmed publisher |
Nasrallah R, Imianowski C, Bossini Castillo L, Grant F, Dogan M, Placek L, et al. A distal enhancer at risk locus 11q13.5 promotes suppression of colitis by Treg cells. Nature. 2020;583:447-452 pubmed publisher |
Yu L, Wang L, Yi H, Wu X. LRP6-CRISPR prevents activation of hepatic stellate cells and liver fibrogenesis in rats. Am J Transl Res. 2020;12:397-408 pubmed |
Petazzi P, Torres Ruiz R, Fidanza A, Roca Ho H, Gutiérrez Agüera F, Castaño J, et al. Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells. Mol Ther Nucleic Acids. 2020;20:196-204 pubmed publisher |
Huang H, Zhong L, Zhou J, Hou Y, Zhang Z, Xing X, et al. Leydig-like cells derived from reprogrammed human foreskin fibroblasts by CRISPR/dCas9 increase the level of serum testosterone in castrated male rats. J Cell Mol Med. 2020;24:3971-3981 pubmed publisher |
Raffeiner P, Hart J, García Caballero D, Bar Peled L, Weinberg M, Vogt P. An MXD1-derived repressor peptide identifies noncoding mediators of MYC-driven cell proliferation. Proc Natl Acad Sci U S A. 2020;117:6571-6579 pubmed publisher |
Wang J, Jiang X, Zhao L, Zuo S, Chen X, Zhang L, et al. Lineage reprogramming of fibroblasts into induced cardiac progenitor cells by CRISPR/Cas9-based transcriptional activators. Acta Pharm Sin B. 2020;10:313-326 pubmed publisher |
Mong E, Yang Y, Akat K, Canfield J, VanWye J, Lockhart J, et al. Chromosome 19 microRNA cluster enhances cell reprogramming by inhibiting epithelial-to-mesenchymal transition. Sci Rep. 2020;10:3029 pubmed publisher |
Yang F, Huang X, Zang R, Chen J, Fidalgo M, Sanchez Priego C, et al. DUX-miR-344-ZMYM2-Mediated Activation of MERVL LTRs Induces a Totipotent 2C-like State. Cell Stem Cell. 2020;26:234-250.e7 pubmed publisher |
Tian C, Ohlund D, Rickelt S, Lidström T, Huang Y, Hao L, et al. Cancer Cell-Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma. Cancer Res. 2020;80:1461-1474 pubmed publisher |
Li K, Liu Y, Cao H, Zhang Y, Gu Z, Liu X, et al. Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing. Nat Commun. 2020;11:485 pubmed publisher |
Roberston M, Raghunathan S, Potaman V, Zhang F, Stewart M, McConnell B, et al. CRISPR-Cas9-induced IGF1 gene activation as a tool for enhancing muscle differentiation via multiple isoform expression. FASEB J. 2020;34:555-570 pubmed publisher |
Deng X, Li S, Kong F, Ruan H, Xu X, Zhang X, et al. Long noncoding RNA PiHL regulates p53 protein stability through GRWD1/RPL11/MDM2 axis in colorectal cancer. Theranostics. 2020;10:265-280 pubmed publisher |
Sajwan S, Mannervik M. Gene activation by dCas9-CBP and the SAM system differ in target preference. Sci Rep. 2019;9:18104 pubmed publisher |
Trigg R, Lee L, Prokoph N, Jahangiri L, Reynolds C, Amos Burke G, et al. The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status. Nat Commun. 2019;10:5428 pubmed publisher |
Zhang S, Feng S, Jiang W, Huang X, Chen J. Construction and optimization of a base editor based on the MS2 system. Animal Model Exp Med. 2019;2:185-190 pubmed publisher |
Weiterer S, Meier Soelch J, Georgomanolis T, Mizi A, Beyerlein A, Weiser H, et al. Distinct IL-1α-responsive enhancers promote acute and coordinated changes in chromatin topology in a hierarchical manner. EMBO J. 2019;:e101533 pubmed publisher |
Singaravelu R, Ahmed N, Quan C, Srinivasan P, Ablenas C, Roy D, et al. A conserved miRNA-183 cluster regulates the innate antiviral response. J Biol Chem. 2019;294:19785-19794 pubmed publisher |
Griukova A, Deryabin P, Shatrova A, Burova E, Severino V, Farina A, et al. Molecular basis of senescence transmitting in the population of human endometrial stromal cells. Aging (Albany NY). 2019;11:9912-9931 pubmed publisher |
Peng W, Koirala P, Zhang W, Ni C, Wang Z, Yang L, et al. lncRNA RMST Enhances DNMT3 Expression through Interaction with HuR. Mol Ther. 2019;: pubmed publisher |
Zhang Z, Lee J, Ruan H, Ye Y, Krakowiak J, Hu Q, et al. Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer. Nat Commun. 2019;10:4562 pubmed publisher |
Luo M, Bai J, Liu B, Yan P, Zuo F, Sun H, et al. H3K18ac Primes Mesendodermal Differentiation upon Nodal Signaling. Stem Cell Reports. 2019;13:642-656 pubmed publisher |
Chen Y, Huang Y, Kanwal M, Li G, Yang J, Niu H, et al. MUC16 in non-small cell lung cancer patients affected by familial lung cancer and indoor air pollution: clinical characteristics and cell behaviors. Transl Lung Cancer Res. 2019;8:476-488 pubmed publisher |
Tong Z, Sathe A, Ebner B, Qi P, Veltkamp C, Gschwend J, et al. Functional genomics identifies predictive markers and clinically actionable resistance mechanisms to CDK4/6 inhibition in bladder cancer. J Exp Clin Cancer Res. 2019;38:322 pubmed publisher |
Pentinmikko N, Iqbal S, Mana M, Andersson S, Cognetta A, Suciu R, et al. Notum produced by Paneth cells attenuates regeneration of aged intestinal epithelium. Nature. 2019;571:398-402 pubmed publisher |
Pontis J, Planet E, Offner S, Turelli P, Duc J, Coudray A, et al. Hominoid-Specific Transposable Elements and KZFPs Facilitate Human Embryonic Genome Activation and Control Transcription in Naive Human ESCs. Cell Stem Cell. 2019;24:724-735.e5 pubmed publisher |
Toska E, Castel P, Chhangawala S, Arruabarrena Aristorena A, Chan C, Hristidis V, et al. PI3K Inhibition Activates SGK1 via a Feedback Loop to Promote Chromatin-Based Regulation of ER-Dependent Gene Expression. Cell Rep. 2019;27:294-306.e5 pubmed publisher |
Shen M, Wang F, Li M, Sah N, Stockton M, Tidei J, et al. Reduced mitochondrial fusion and Huntingtin levels contribute to impaired dendritic maturation and behavioral deficits in Fmr1-mutant mice. Nat Neurosci. 2019;22:386-400 pubmed publisher |
Lu B, Klingbeil O, Tarumoto Y, Somerville T, Huang Y, Wei Y, et al. A Transcription Factor Addiction in Leukemia Imposed by the MLL Promoter Sequence. Cancer Cell. 2018;34:970-981.e8 pubmed publisher |
Chong Z, Ohnishi S, Yusa K, Wright G. Pooled extracellular receptor-ligand interaction screening using CRISPR activation. Genome Biol. 2018;19:205 pubmed publisher |
Zhang P, Kang B, Xie G, Li S, Gu Y, Shen Y, et al. Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer. Cancer Lett. 2018;442:53-67 pubmed publisher |
Liu L, Huang M, Dai P, Liu T, Fan S, Cheng X, et al. Intrinsic Nucleotide Preference of Diversifying Base Editors Guides Antibody Ex Vivo Affinity Maturation. Cell Rep. 2018;25:884-892.e3 pubmed publisher |
Fauster A, Rebsamen M, Willmann K, César Razquin A, Girardi E, Bigenzahn J, et al. Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking. Cell Death Differ. 2019;26:1138-1155 pubmed publisher |
Zhang Y, Arango G, Li F, Xiao X, Putatunda R, Yu J, et al. Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling. BMC Med Genomics. 2018;11:78 pubmed publisher |
Weltner J, Balboa D, Katayama S, Bespalov M, Krjutskov K, Jouhilahti E, et al. Human pluripotent reprogramming with CRISPR activators. Nat Commun. 2018;9:2643 pubmed publisher |
Bester A, Lee J, Chavez A, Lee Y, Nachmani D, Vora S, et al. An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance. Cell. 2018;173:649-664.e20 pubmed publisher |
Jia Y, Xu R, Ren X, Ewen Campen B, Rajakumar R, ZIRIN J, et al. Next-generation CRISPR/Cas9 transcriptional activation in Drosophila using flySAM. Proc Natl Acad Sci U S A. 2018;115:4719-4724 pubmed publisher |
Vad Nielsen J, Nielsen A, Luo Y. Simple method for assembly of CRISPR synergistic activation mediator gRNA expression array. J Biotechnol. 2018;274:54-57 pubmed publisher |
Passaia B, Dias M, Kremer J, Antonini S, de Almeida M, Fragoso M, et al. TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, as a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors. Front Endocrinol (Lausanne). 2018;9:38 pubmed publisher |
Guallar D, Bi X, Pardavila J, Huang X, Sáenz C, Shi X, et al. RNA-dependent chromatin targeting of TET2 for endogenous retrovirus control in pluripotent stem cells. Nat Genet. 2018;50:443-451 pubmed publisher |
Palau A, Garz A, Diesch J, Zwick A, Malinverni R, Valero V, et al. Polycomb protein RING1A limits hematopoietic differentiation in myelodysplastic syndromes. Oncotarget. 2017;8:115002-115017 pubmed publisher |
Lu J, Zhao C, Zhao Y, Zhang J, Zhang Y, Chen L, et al. Multimode drug inducible CRISPR/Cas9 devices for transcriptional activation and genome editing. Nucleic Acids Res. 2018;46:e25 pubmed publisher |
Liao H, Hatanaka F, Araoka T, Reddy P, Wu M, Sui Y, et al. In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation. Cell. 2017;171:1495-1507.e15 pubmed publisher |
Moretti A, Pavanelli J, Nolasco P, Leisegang M, Tanaka L, Fernandes C, et al. Conserved Gene Microsynteny Unveils Functional Interaction Between Protein Disulfide Isomerase and Rho Guanine-Dissociation Inhibitor Families. Sci Rep. 2017;7:17262 pubmed publisher |
Kweon J, Jang A, Kim D, Yang J, Yoon M, Rim Shin H, et al. Fusion guide RNAs for orthogonal gene manipulation with Cas9 and Cpf1. Nat Commun. 2017;8:1723 pubmed publisher |
Bonev B, Mendelson Cohen N, Szabo Q, Fritsch L, Papadopoulos G, Lubling Y, et al. Multiscale 3D Genome Rewiring during Mouse Neural Development. Cell. 2017;171:557-572.e24 pubmed publisher |
Lundh M, Plucińska K, Isidor M, Petersen P, Emanuelli B. Bidirectional manipulation of gene expression in adipocytes using CRISPRa and siRNA. Mol Metab. 2017;6:1313-1320 pubmed publisher |
Li S, Zhang A, Xue H, Li D, Liu Y. One-Step piggyBac Transposon-Based CRISPR/Cas9 Activation of Multiple Genes. Mol Ther Nucleic Acids. 2017;8:64-76 pubmed publisher |
Liu S, Yu X, Wang Q, Liu Z, Xiao Q, Hou P, et al. Specific Expression of Interferon-? Induced by Synergistic Activation Mediator-Derived Systems Activates Innate Immunity and Inhibits Tumorigenesis. J Microbiol Biotechnol. 2017;27:1855-1866 pubmed publisher |
Ewen Campen B, Yang Zhou D, Fernandes V, González D, Liu L, Tao R, et al. Optimized strategy for in vivo Cas9-activation in Drosophila. Proc Natl Acad Sci U S A. 2017;114:9409-9414 pubmed publisher |
Joung J, Engreitz J, Konermann S, Abudayyeh O, Verdine V, Aguet F, et al. Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood. Nature. 2017;548:343-346 pubmed publisher |
Ho S, Hartley B, Flaherty E, Rajarajan P, Abdelaal R, Obiorah I, et al. Evaluating Synthetic Activation and Repression of Neuropsychiatric-Related Genes in hiPSC-Derived NPCs, Neurons, and Astrocytes. Stem Cell Reports. 2017;9:615-628 pubmed publisher |
Fidanza A, Lopez Yrigoyen M, Romano N, Jones R, Taylor A, Forrester L. An all-in-one UniSam vector system for efficient gene activation. Sci Rep. 2017;7:6394 pubmed publisher |
Nowicki Osuch K, Li Y, Challinor M, Gerrard D, Hanley N, Sharrocks A. EINCR1 is an EGF inducible lincRNA overexpressed in lung adenocarcinomas. PLoS ONE. 2017;12:e0181902 pubmed publisher |
Gocheva V, Naba A, Bhutkar A, Guardia T, Miller K, Li C, et al. Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival. Proc Natl Acad Sci U S A. 2017;114:E5625-E5634 pubmed publisher |
Tammela T, Sanchez Rivera F, Cetinbas N, Wu K, Joshi N, Helenius K, et al. A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma. Nature. 2017;545:355-359 pubmed publisher |
Solvsten C, Daugaard T, Luo Y, de Paoli F, Christensen J, Nielsen A. The Effects of Voluntary Physical Exercise-Activated Neurotrophic Signaling in Rat Hippocampus on mRNA Levels of Downstream Signaling Molecules. J Mol Neurosci. 2017;62:142-153 pubmed publisher |
Joung J, Konermann S, Gootenberg J, Abudayyeh O, Platt R, Brigham M, et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat Protoc. 2017;12:828-863 pubmed publisher |
Schwarz K, Daringer N, Dolberg T, Leonard J. Rewiring human cellular input-output using modular extracellular sensors. Nat Chem Biol. 2017;13:202-209 pubmed publisher |
Xiong K, Zhou Y, Hyttel P, Bolund L, Freude K, Luo Y. Generation of induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM). Stem Cell Res. 2016;17:665-669 pubmed publisher |
Hess G, Frésard L, Han K, Lee C, Li A, Cimprich K, et al. Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells. Nat Methods. 2016;13:1036-1042 pubmed publisher |
Zhu S, Li W, Liu J, Chen C, Liao Q, Xu P, et al. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library. Nat Biotechnol. 2016;34:1279-1286 pubmed publisher |
Ho T, Huang J, Zhou N, Zhang Z, Koirala P, Zhou X, et al. Regulation of PCGEM1 by p54/nrb in prostate cancer. Sci Rep. 2016;6:34529 pubmed publisher |
Chavez A, Tuttle M, Pruitt B, Ewen Campen B, Chari R, Ter Ovanesyan D, et al. Comparison of Cas9 activators in multiple species. Nat Methods. 2016;13:563-567 pubmed publisher |
Kennedy E, Bogerd H, Kornepati A, Kang D, Ghoshal D, Marshall J, et al. Posttranscriptional m(6)A Editing of HIV-1 mRNAs Enhances Viral Gene Expression. Cell Host Microbe. 2016;19:675-85 pubmed publisher |
Bogerd H, Kornepati A, Marshall J, Kennedy E, Cullen B. Specific induction of endogenous viral restriction factors using CRISPR/Cas-derived transcriptional activators. Proc Natl Acad Sci U S A. 2015;112:E7249-56 pubmed publisher |
Limsirichai P, Gaj T, Schaffer D. CRISPR-mediated Activation of Latent HIV-1 Expression. Mol Ther. 2016;24:499-507 pubmed publisher |
Saayman S, Lazar D, Scott T, Hart J, Takahashi M, Burnett J, et al. Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex. Mol Ther. 2016;24:488-98 pubmed publisher |
Zhang Y, Yin C, Zhang T, Li F, Yang W, Kaminski R, et al. CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs. Sci Rep. 2015;5:16277 pubmed publisher |
Konermann S, Brigham M, Trevino A, Joung J, Abudayyeh O, Bárcena C, et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 2015;517:583-8 pubmed publisher |
